Ticker
PFE

Price
26.58
Stock movement down
-0.08 (-0.30%)
Company name
Pfizer Inc
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers-General
Market cap
150.03B
Ent value
250.90B
Price/Sales
1.50
Price/Book
1.56
Div yield
6.32%
Div growth
4.94%
Growth years
11
FCF payout
47.27%
Trailing P/E
4.78
Forward P/E
7.03
PEG
0.89
EPS growth
9.24%
1 year return
-36.03%
3 year return
-9.66%
5 year return
-8.07%
10 year return
-1.39%
Last updated: 2024-04-08

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

BUSINESS INSIGHT

Segment Revenues ($M)

Loading...
Covid-19 vaccine comments

BNT162b2, which was granted an emergency use authorization (EUA) in the U.S. in December 2020, and which contributed $154 million in sales in the fourth quarter

Geographic Revenues ($M)

Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.68
Dividend yield6.32%
Payout frequencyQuarterly
Maximum yield6.49%
Average yield4.02%
Minimum yield2.61%
Discount to avg yield36.35%
Upside potential57.10%
Yield as % of max yield97.40%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield6.32%
Current yield distribution0.32%
Yield at 100% (Min)2.61%
Yield at 90%3.15%
Yield at 80%3.34%
Yield at 50% (Median)3.97%
Yield at 20%4.47%
Yield at 10%5.06%
Yield at 0% (Max)6.49%

Dividend per share

Loading...
Dividend per share data
Years of growth11 years
CCC statusDividend Contender
Dividend per share1.68
Payout frequencyQuarterly
Ex-div date25 Jan 2024
EPS (TTM)5.46
EPS (1y forward)3.78
EPS growth (5y)9.24%
EPS growth (5y forward)5.37%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
PFES&P500
DGR MR2.44%-16.32%
DGR TTM2.48%4.05%
DGR 3 years4.43%5.24%
DGR 5 years4.94%5.40%
DGR 10 years6.07%7.07%
DGR 15 years2.03%6.12%
Time since last change announced125 days
EPS growth (5y)9.24%
EPS growth (5y forward)5.37%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM30.33%47.27%
Average--
Forward44.44%-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E4.78
Price to OCF5.13
Price to FCF7.45
Price to EBITDA4.93
EV to EBITDA8.24

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.50
Price to Book1.56
EV to Sales2.50

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count5.64B
EPS (TTM)5.46
FCF per share (TTM)3.51

Income statement

Loading...
Income statement data
Revenue (TTM)100.33B
Gross profit (TTM)65.99B
Operating income (TTM)37.28B
Net income (TTM)31.37B
EPS (TTM)5.46
EPS (1y forward)3.78

Margins

Loading...
Margins data
Gross margin (TTM)65.77%
Operating margin (TTM)37.15%
Profit margin (TTM)31.27%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash416.00M
Net receivables10.95B
Total current assets51.26B
Goodwill51.38B
Intangible assets43.37B
Property, plant and equipment16.27B
Total assets197.21B
Accounts payable6.81B
Short/Current long term debt35.83B
Total current liabilities42.14B
Total liabilities101.29B
Shareholder's equity95.92B
Net tangible assets95.66B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)29.27B
Capital expenditures (TTM)3.24B
Free cash flow (TTM)20.13B
Dividends paid (TTM)9.52B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity32.71%
Return on Assets15.91%
Return on Invested Capital23.81%
Cash Return on Invested Capital15.28%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open26.60
Daily high26.82
Daily low26.52
Daily Volume24.4M
All-time high61.25
1y analyst estimate50.97
Beta0.59
EPS (TTM)5.46
Dividend per share1.68
Ex-div date25 Jan 2024
Next earnings date1 May 2024

Downside potential

Loading...
Downside potential data
PFES&P500
Current price drop from All-time high-56.60%-0.85%
Highest price drop-76.70%-56.47%
Date of highest drop2 Mar 20099 Mar 2009
Avg drop from high-30.40%-11.35%
Avg time to new high36 days13 days
Max time to new high5620 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
PFE (Pfizer Inc) company logo
Marketcap
150.03B
Marketcap category
Large-cap
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Employees
83000
SEC filings
CEO
Albert Bourla
Country
USA
City
New York
Stock type
Common stock
CCC status
Dividend Contender
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...